olivlawolivlaw

olivLaw · US equity research

Radian Group Inc. RDN

Surety Insurance · SIC 6351 · Vertical: Surety Insurance (SIC 6351)

36.56USD+2.01% · 1 dayClose 04 Nov 2026

Radian Group is a U.S. mortgage insurer that, after the February 2026 Inigo acquisition, has become a global multi-line specialty insurer. For the second quarter of 2026 the company reported revenue of 575 million USD, and the Specialty segment reached 53% of net premiums earned, a shift in profile relevant to investors.

At the close of 04 Nov 2026, Radian Group Inc. (RDN) stock was 36.56 USD (+2.01% on the day), with market capitalisation 4.8 bn USD, P/E 9.4 on diluted EPS of 3.89 USD over the last 12 months, dividend yield 2.79%, beta 0.46, 52-week range 30.61–39.71 USD. Latest reported quarter (Q2 2026): revenue of 575.0 m USD (+92.6% YoY), net income of 115.9 m USD (−18.3% YoY), diluted EPS 0.85 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
4.8 bn USD
shares as of 05 Aug 2026
P/E (TTM)
9.4
Diluted EPS TTM 3.89 · TTM to 30 Jun 2026
E/P (TTM)
10.64%
TTM to 30 Jun 2026
Dividend yield
2.79%
DPS 12m 1.02
Beta (2y)
0.46
Volatility (1y) 26%
52-week range
30.6139.71

Price history

Loading chart…

Technical reading

RSI (14)
62.7
strong (55–70)
Bollinger (20, 2)
32.90 – 36.72
in the upper half of the band · %B 0.96 · band width 11.0%
SMA 50 / 200
34.79 / 35.26
mixed trend
MACD (12, 26, 9)
0.48 / 0.25
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+9.1%−1.1%+10.2 pp—
3 months−6.7%−0.5%−6.2 pp—
6 months+2.3%+4.4%−2.1 pp—
Year to date+1.6%+12.3%−10.7 pp—
1 year+6.6%+13.5%−7.0 pp−13.3%
3 years+34.8%+76.4%−41.7 pp+36.3%
5 years+60.6%+63.7%−3.1 pp—
Max drawdown (1y)
−22.9%
29 Jul 2026 → 30 Sept 2026
Max drawdown (5y)
−26.5%
02 Mar 2022 → 16 Jun 2022
Compound annual growth (5y)
+9.9%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2026 · 30 Jun 2026

Revenue
575.0 m USD
+92.6% YoY
Net income
115.9 m USD
−18.3% YoY
Diluted EPS
0.85
−16.7% YoY
net / operating
20.2% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue313.4 m292.7 m294.8 m298.6 m303.2 m300.5 m466.3 m575.0 m
Cost of revenue9.5 m9.9 m8.8 m8.4 m————
Depreciation & amortisation12.3 m ≈-31.6 m14.4 m26.7 m ≈2.6 m ≈-33.7 m——
Interest expense21.9 m16.6 m16.5 m17.4 m17.2 m17.2 m20.6 m22.3 m
Pre-tax income214.3 m210.4 m198.7 m192.8 m198.7 m201.0 m173.7 m150.7 m
Income tax47.8 m46.6 m46.6 m38.3 m45.9 m42.2 m44.2 m32.5 m
Net income151.9 m148.3 m144.6 m141.8 m141.4 m154.8 m124.1 m115.9 m
Diluted EPS0.990.980.981.021.031.120.890.85
Operating cash flow-237.9 m ≈-269.4 m67.8 m-713.3 m ≈358.4 m ≈407.0 m285.0 m342.9 m ≈
Capex-1.2 m ≈172.0 k1.1 m1.2 m ≈1.0 m ≈870.0 k749.0 k225.0 k ≈
Dividends paid37.2 m ≈36.7 m37.3 m38.6 m ≈34.8 m ≈34.9 m35.3 m37.3 m ≈
Share repurchases49.0 m ≈76.0 m208.9 m223.0 m ≈0 ≈050.0 m80.3 m ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 74 percentile of its own 39-quarter history (min 4.2, median 8.1, max 38.2; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue1.3 bn1.5 bn1.4 bn1.3 bn1.2 bn1.2 bn1.2 bn1.2 bn
Revenue YoY+4.2%+19.9%−5.8%−7.6%−10.5%−1.1%+2.5%−0.8%
Net income606.0 m672.3 m393.6 m600.7 m742.9 m603.1 m604.4 m582.6 m
Net income YoY+400.5%+10.9%−41.5%+52.6%+23.7%−18.8%+0.2%−3.6%
Diluted EPS2.773.202.003.164.353.773.924.14
Diluted EPS YoY+403.6%+15.5%−37.5%+58.0%+37.7%−13.3%+4.0%+5.6%
net %47.6%44.0%27.4%45.2%62.4%51.2%50.1%48.7%
Free cash flowunavailableunavailableunavailable544.5 m370.6 m520.9 m-665.1 m115.7 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
24.8 m USD
Financial debt
1.1 bn USD
Net debt
1.1 bn USD
Equity
4.8 bn USD
Total assets
8.1 bn USD
Debt / equity
0.23x
Current ratio
unavailable
ROE
12.4%
ROA
6.9%
FCF margin
9.7%

Financial statements (source on every figure)

Revenue and net income (USD)

Income statement · USD

Pre-tax income
2023
863.9 m
2024
845.6 m
2025
791.2 m

SEC (XBRL)· 20 Feb 2026verified

Net income
2023
603.1 m
2024
604.4 m
2025
582.6 m

SEC (XBRL)· 20 Feb 2026verified

Diluted EPS
2023
3.77
2024
3.92
2025
4.14

SEC (XBRL)· 20 Feb 2026verified

Dividend per share
2023
0.90
2024
0.98
2025
1.02

SEC (XBRL)· 20 Feb 2026verified

Balance sheet · USD

Cash
2023
19.0 m
2024
19.2 m
2025
24.8 m

SEC (XBRL)· 20 Feb 2026verified

Total assets
2023
7.6 bn
2024
8.7 bn
2025
8.1 bn

SEC (XBRL)· 20 Feb 2026verified

Short-term debt
2023
—
2024
—
2025
33.3 m

SEC (XBRL)· 08 May 2026verified

Long-term debt
2023
—
2024
—
2025
1.1 bn

SEC (XBRL)· 08 May 2026verified

Total liabilities
2023
3.2 bn
2024
4.1 bn
2025
3.3 bn

SEC (XBRL)· 20 Feb 2026verified

Equity
2023
4.4 bn †
2024
4.6 bn †
2025
4.8 bn †

SEC (XBRL)· 20 Feb 2026verified

Cash flow · USD

Dividends paid
2023
145.9 m
2024
152.0 m
2025
145.6 m

SEC (XBRL)· 20 Feb 2026verified

Share repurchases
2023
133.3 m
2024
225.1 m
2025
431.9 m

SEC (XBRL)· 20 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
-0.8%
computed by olivLawFY 2025
Revenue CAGR 3Y
0.2%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
-3.6%
computed by olivLawFY 2020 → FY 2025
Net income growth (YoY)
-3.6%
computed by olivLawFY 2025
Net income CAGR 3Y
-7.8%
computed by olivLawFY 2022 → FY 2025
Net income CAGR 5Y
8.2%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
5.6%
computed by olivLawFY 2025
EPS CAGR 3Y
-1.6%
computed by olivLawFY 2022 → FY 2025
EPS CAGR 5Y
15.7%
computed by olivLawFY 2020 → FY 2025

Profitability

Net margin
32.6%
computed by olivLawTTM to 30 Jun 2026

Returns

ROE
11.5%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
5.3%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Payout ratio (EPS)
26.2%
computed by olivLawTTM to 30 Jun 2026

Market and valuation

Market capitalisation
4.8 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Market cap / net income TTM
9.0x
computed by olivLawTTM to 30 Jun 2026
P/E (TTM)
9.4x
computed by olivLawTTM to 30 Jun 2026
Earnings yield
10.6%
computed by olivLawTTM to 30 Jun 2026
P/B
1.0x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
2.9x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
2.8%
computed by olivLawTTM to 30 Jun 2026
Shareholder yield (distributions)
5.6%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

Insurance

Loss ratio
unavailable
input data missing

32 indicators that do not apply to the sector.

Valuation

olivLaw classification

Neutral profile

Score: 47 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

36.56 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 4.8 bn USD

Key indicators

Market capitalisation
4.8 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
9.4x
computed by olivLawTTM to 30 Jun 2026
P/B
1.0x
computed by olivLawbalance sheet at 30 Jun 2026
ROE
11.5%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
32.6%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
-0.8%
computed by olivLawFY 2025
Dividend yield
2.8%
computed by olivLawTTM to 30 Jun 2026

Coverage and freshness

12/20 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 05 Aug 2026
Source: SEC (XBRL)published 07 Aug 2026
verified 1910derived 148

Score by group

  • Balance sheet100
  • Valuation53
  • Quality33
  • Growth1
  • Returns75

Estimated value range

Low
35.01
USD per share
Mid
38.18
USD per share
High
39.05
USD per share
Price: 36.56 USD
The price is within the range
Potential to the central value: 4.4% (value / price − 1)
Margin of safety: 4.3% (1 − price / value)
Agreement between methods: medium · 5 methods used · 4 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 13.40 – 56.60 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • Residual income37.34 – 39.05 (Mid 38.18)
  • Justified P/B42.08 – 56.60 (Mid 48.27)
  • Dividend discount (DDM)13.40 – 18.03 (Mid 15.38)
  • Peers: P/E35.01 – 37.50 (Mid 35.16)
    5 companies used · median multiple 9.0x · quartiles 9.0x – 9.6x
    AGO, ESNT, MTG, NMIH, ORI
  • Peers: P/B25.64 – 44.18 (Mid 41.72)
    6 companies used · median multiple 1.1x · quartiles 0.7x – 1.2x
    AGO, ESNT, MTG, NMIH, ORI, OSG
Multiple comparisons use the SIC vertical: Surety Insurance (SIC 6351)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 47/100

FactorValueScoreWeight used
ROE · Quality11.5%33 (vs peers)20%
Loss ratio · Qualityunavailableunavailable—
EPS CAGR 3Y · Growth-1.6%0 (on a fixed band)11%
Revenue CAGR 3Y · Growth0.2%2 (on a fixed band)9%
ROA · Balance sheet5.3%100 (on a fixed band)9%
P/B · Valuation1.0x67 (vs peers)16%
P/E (TTM) · Valuation9.4x40 (vs peers)16%
Dividend yield · Returns2.8%60 (vs peers)11%
Payout ratio (EPS) · Returns26.2%100 (on a fixed band)7%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet100/100 · 1/1 factors with a value
  • Growth1/100 · 2/2 factors with a value
  • Quality· partial33/100 · 1/2 factors with a value
  • Returns75/100 · 2/2 factors with a value
  • Valuation53/100 · 2/2 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

RADIAN GROUP INC (RDN). Latest full fiscal year: 2025; data up to 2026-06-30.

Figures computed from the financial statements: YoY growth -0.8%; net margin 32.6%; ROE 11.5%.

The estimated value range is 35.01–39.05 USD per share (median of 5 methods, agreement: medium); assumptions are illustrative. Against the central value of 38.18 USD, the price of 36.56 USD leaves a potential of 4.4% (value / price − 1) and a margin of safety of 4.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 47/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: quality. Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROA: 5.3%
  • Payout ratio (EPS): 26.2%

What contradicts it

  • EPS CAGR 3Y: -1.6%
  • Revenue CAGR 3Y: 0.2%

Not assessed (insufficient data or a ratio without meaning): Loss ratio.

Versus the vertical median

Surety Insurance (SIC 6351) · same industry (4-digit SIC) · compared with 7 companies

Multiples and returns vs the median

P/E
9.4x
vertical median 9.0x
at median
EV/EBITDA
—
vertical median —
P/S
2.9x
vertical median 3.4x
below median (−13.3%)
P/B
1.0x
vertical median 1.1x
below median (−12.4%)
ROE
11.5%
vertical median 12.9%
below median (−10.7%)
Net margin
32.6%
vertical median 37.3%
below median (−12.7%)
EBIT margin
—
vertical median —
Revenue YoY
-0.8%
vertical median 8.5%
below median (−109.0%)
Net debt/EBITDA
—
vertical median —
Dividend yield
2.8%
vertical median 2.1%
above median (+31.1%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ORIOld Republic International Corporation9.6 bn9.017.9%11.2%+11.0%−13% / +36%
ESNTEssent Group Ltd.6.2 bn9.712.0%51.5%+1.5%+10% / +43%
MTGMGIC Investment Corp5.8 bn9.013.8%58.1%+0.5%+3% / +66%
RDNRadian Group Inc4.8 bn9.411.5%32.6%−0.8%+7% / +35%
NMIHNMI Holdings, Inc.3.3 bn8.615.4%54.1%+8.5%+15% / +60%
AGOAssured Guaranty Ltd.3.2 bn9.66.3%37.3%+27.3%−20% / +7%
OSGOctave Specialty Group, Inc.235.2 m—-20.4%-49.6%+6.5%−42% / −65%
MBIMbia Inc.230.6 m——-149.5%+90.5%−40% / −38%

1- and 3-year price returns: for RDN from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
21.54
Total return -39% · Per year -39%
38.17
Total return 7% · Per year 7%
57.60
Total return 61% · Per year 61%
3 years
19.13
Total return -41% · Per year -16%
38.30
Total return 14% · Per year 4%
63.72
Total return 85% · Per year 23%
5 years
16.99
Total return -44% · Per year -11%
38.44
Total return 20% · Per year 4%
70.49
Total return 112% · Per year 16%
What moves the 3-year price the most
  • Exit P/E± 9.58
  • Net margin± 6.70
  • Annual revenue growth± 5.74
  • Annual dilution± 0.56

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Radian Group is a U.S. mortgage insurer that, after the February 2026 Inigo acquisition, has become a global multi-line specialty insurer. For the second quarter of 2026 the company reported revenue of 575 million USD, and the Specialty segment reached 53% of net premiums earned, a shift in profile relevant to investors.

SWOT

Strengths

  • Leading position in private mortgage insurance and a large insured portfolio of high-quality loans 1.
  • Capital generation capacity in the Mortgage segment, supported by large dividends from the insurance subsidiary 2.
  • Diversification through the Specialty segment, which broadened the revenue base after the Inigo acquisition 3.

Weaknesses

  • Historical dependence on one segment, mortgage insurance, exposes the company to the housing cycle and government policy 1.
  • The Specialty segment posted a high combined ratio in the second quarter, showing pressure on margins 3.
  • Integrating Inigo and its control systems could slow the realization of expected benefits 2.

Opportunities

  • Growth in mortgage credit volume and purchase demand could support new insurance written 1.
  • Expansion into specialty insurance and reinsurance could diversify revenues if markets remain favorable 2.
  • Completing the sale of non-core businesses could simplify the portfolio and focus capital on insurance 3.

Threats

  • Changes in regulation and GSE PMIERs requirements could reduce the capital flexibility of the insurance subsidiary 1.
  • Deterioration in credit or house prices could increase portfolio losses 1.
  • Softening Specialty pricing and geopolitical events could affect reinsurance results 23.

Risks

  • GSE eligibilityhigh

    If the Radian Guaranty subsidiary fails to maintain its eligibility under PMIERs, the mortgage insurance business could face significant restrictions 1.

  • Inigo integrationmedium

    Integrating a Lloyd's company, its systems and internal controls could create unforeseen operational and financial risks 2.

  • Specialty underwriting riskhigh

    Loss reserves tied to geopolitical conflicts could rise if claims expand 3.

  • Housing cyclemedium

    A decline in house prices or a rise in unemployment could affect default rates and Mortgage segment results 1.

  • Holding company liquiditylow

    Available holding company liquidity fell to 412 million USD at June 30, 2026, which could limit share repurchases and dividends 3.

Investment thesis

What would need to be true (bull case)

  • If the Mortgage segment keeps its profitability and capital generation, the company could fund Specialty growth without reducing dividends.
  • Diversifying into specialty insurance could reduce dependence on the mortgage cycle and could stabilize long-term revenues.
  • Simplifying the portfolio by selling non-core businesses could focus management on the core insurance franchise.

What would break the thesis

  • If the Specialty combined ratio stays high, consolidated margins could be compressed in coming quarters.
  • PMIERs and Basel III rules could limit the subsidiary's ability to distribute capital to the holding company.
  • Integrating Inigo and a change in leadership could delay strategy execution and affect investor confidence.

What to watch

  • Combined ratio and reserve trends in the Specialty segment after the Inigo integrationQ3 2026
  • Completion of the Title business sale and its effect on assets held for saleend of 2026
  • Ordinary dividends from Radian Guaranty to the holding company, expected at about 650 million USD2026
  • Primary loan default rate and credit trends in the Mortgage portfolionext 10-Q

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Radian Group is a holding company operating through insurance subsidiaries and presents itself as a major provider of private mortgage insurance in the United States. Its core activity, the Mortgage Insurance segment, distributes U.S. mortgage credit risk for lenders and mortgage credit investors, mainly through private insurance on first-lien residential loans 1. In 2025 the company wrote 55.2 billion USD of new insurance (NIW), and insurance in force (IIF) reached 282.5 billion USD at December 31, 2025 1. Since February 2026, after the Inigo acquisition, the company reports two segments, Mortgage and Specialty 2.

Segments

Mortgage

The Mortgage segment insures residential mortgage loans, and its profitability depends on premiums earned, default-related losses and portfolio persistency. In the second quarter of 2026, primary insurance in force reached 284 billion USD and new insurance written was 16 billion USD 3. The segment combined ratio was 36%, indicating a high operating margin 3.

Specialty

The Specialty segment, introduced through the Inigo acquisition, covers specialty insurance and reinsurance through Lloyd's. In the second quarter of 2026, total gross premiums written were 504 million USD, of which 275 million was reinsurance, and the combined ratio was 98% 3. The segment is still being integrated, and its results may fluctuate with market conditions and loss reserves 2.

Market context

According to the 10-K, total mortgage originations could reach about 2.3 trillion USD in 2026, an increase of 15% over 2025, and the private mortgage insurance market could be moderately larger than the estimated 300 billion USD in 2025 1. Low refinancing activity and stable credit support persistency, but penetration depends on competition with FHA and VA 1. In Specialty, rates are softening across several insurance and reinsurance lines, which could reduce premium income 2.

Trends

  • Refinancing rate sensitivitymixed

    If interest rates decline, refinancing activity could rise, which could affect portfolio persistency and premium income 1.

  • Softening reinsurance pricesheadwind

    Excess capacity after a benign 2025 loss year could compress premiums in specialty lines, including reinsurance 12.

  • Credit score modernizationmixed

    The GSE shift to VantageScore 4.0 and FICO 10T is not expected by management to have a material impact on the business 2.

  • Basel III rules for mortgage insurancemixed

    March 2026 proposals keep mortgage insurance as a prudent underwriting standard but could change risk weights, with future effects on bank demand 2.

Competitive position

Private mortgage insurance competes among private insurers and with the federal FHA and VA programs on price and other factors 1. Risk-based pricing and PMIERs capital conditions shape each insurer's competitive position 1. In Specialty, competition in Lloyd's and reinsurance markets varies by line and available capacity 2.

  • Mortgage Guaranty Insurance Corporation

    Direct competitor in private mortgage insurance, named in the market context of the available sources without its own financial data.

  • Essent GroupESNT

    Private mortgage insurer competing in the same U.S. market and business category.

  • MGIC Investment CorporationMTG

    Private mortgage insurer competing in the same market segment.

  • Federal Housing Administration

    Public program competing with private insurance for eligible mortgage loans.

News & filings

In the press

No news in our archive over the last 180 days.

SEC filings

  • Current report03 Nov 2026
    Material agreement · Creation of a direct financial obligation · Financial statements and exhibits
  • Current report28 Oct 2026
    Departure or appointment of officers
  • Current report11 Aug 2026
    Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
  • Quarterly report07 Aug 2026
  • Current report06 Aug 2026
    Results of operations · Financial statements and exhibits
  • Current report27 May 2026
    Departure or appointment of officers · Shareholder vote
  • Current report21 May 2026
    Departure or appointment of officers · Financial statements and exhibits
  • Quarterly report08 May 2026
  • Current report07 May 2026
    Results of operations · Financial statements and exhibits
  • Current report21 Apr 2026
    Departure or appointment of officers

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Radian Group Inc. · 20 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Radian Group Inc. · 07 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Radian Group Inc. · 06 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.